Dr. Nancy L. Lewis On Resistance Among Gist Patients And Regorafenib

Dr. Nancy L. Lewis on Resistance Among GIST Patients and Regorafenib

Targeted Oncology

Dr. Nancy L. Lewis Discusses the CORRECT Trial for Regorafenib in Metastatic Colorectal Cancer

Dr. Nancy L. Lewis Explains the Implications of the GRID study

Targeted Oncology

Dr. Nancy L. Lewis on Targeted Therapies in Gastroesophageal Cancer

Targeted Oncology

Gastrointestinal Stromal Tumor (GIST) of the Stomach

Hassan Aziz, MD

Nancy Lewis Harmon

Dr. George Demetri Describes the Mechanism of Action of Regorafenib in GIST

Medical oncologist Nancy L. Lewis, MD

JeffersonCloseUp

Dr. George Demetri Discusses Regorafenib for Patients with GIST Trial Results

Regorafenib as a treatment for GIST (Gastrointestinal Stromal Tumour) patients

Second- and Third-Line Therapies in Colorectal Cancer

Treating patients with aortic regurgitation and root dilatations | Malakh Shrestha, MBBS, FRCS, PhD

Minneapolis Heart Institute Foundation

Colorectal Cancer Rx Shows More Promise

Living with Gaucher: Nate's Story

National Gaucher Foundation

George D. Demetri: GRID trial

Revolutionizing Health with Dry Blood Analysis: Insights from Global Health Clinics

Global Health Clinics

ENDOCRINE SYSTEM PATHOLOGY LECTURE # 64 THYROID NODULES & THYROID CANCER PATHOLOGY REVIEW

Prometric Medical Education Center

Brain Cancer: Understanding the Disease

GIST

Breakout Session - Simplifying the Science in NMO/SD: Tolerization

The Guthy-Jackson Charitable Foundation